View in EDS

T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.

Saved in:
Bibliographic Details
Title: T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.
Authors: Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Compérat EM; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Plass K; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands., Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Hernández V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Čapoun O; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Pešl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Maxim Bruins H; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Seles M; Department of Urology, Medical University of Graz, Graz, Austria., Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria., Bosschieter J; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Kusuma VRM; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Ashabere D; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Cotte J; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC no. 5, Oncotype-Uro, Sorbonne University, Paris, France., Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Masson-Lecomte A; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Liedberg F; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Cohen D; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK., Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Cussenot O; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., El Sheikh S; Department of Pathology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK., Volanis D; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK., Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP, Pierre et Marie Curie Medical School, Sorbonne University, Paris, France., Rouprêt M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC no. 5, Oncotype-Uro, Sorbonne University, Paris, France., Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Shariat SF; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Mostafid AH; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Zigeuner R; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria., Dominguez-Escrig JL; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Burger M; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Evert M; Department of Pathology, University of Regensburg, Regensburg, Germany., Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., A L M Kiemeney L; Department of Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Soukup V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Gontero P; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Algaba F; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Palou J; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., N'Dow J; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands., Ribal MJ; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands., van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Babjuk M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Sylvester RJ; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: b.v.rhijn@nki.nl.
Source: European urology focus [Eur Urol Focus] 2022 Nov; Vol. 8 (6), pp. 1627-1634. Date of Electronic Publication: 2022 May 14.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101665661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4569 (Electronic) Linking ISSN: 24054569 NLM ISO Abbreviation: Eur Urol Focus Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35577750
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Beijert+IJ%22">Beijert IJ</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hentschel+AE%22">Hentschel AE</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bründl+J%22">Bründl J</searchLink>; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Compérat+EM%22">Compérat EM</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Plass+K%22">Plass K</searchLink>; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Rodríguez+O%22">Rodríguez O</searchLink>; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Subiela+Henríquez+JD%22">Subiela Henríquez JD</searchLink>; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Hernández+V%22">Hernández V</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22de+la+Peña+E%22">de la Peña E</searchLink>; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Alemany+I%22">Alemany I</searchLink>; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Turturica+D%22">Turturica D</searchLink>; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Pisano+F%22">Pisano F</searchLink>; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Soria+F%22">Soria F</searchLink>; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Čapoun+O%22">Čapoun O</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Bauerová+L%22">Bauerová L</searchLink>; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Pešl+M%22">Pešl M</searchLink>; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Maxim+Bruins+H%22">Maxim Bruins H</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Runneboom+W%22">Runneboom W</searchLink>; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Herdegen+S%22">Herdegen S</searchLink>; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Breyer+J%22">Breyer J</searchLink>; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Brisuda+A%22">Brisuda A</searchLink>; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Calatrava+A%22">Calatrava A</searchLink>; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Rubio-Briones+J%22">Rubio-Briones J</searchLink>; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Seles+M%22">Seles M</searchLink>; Department of Urology, Medical University of Graz, Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Mannweiler+S%22">Mannweiler S</searchLink>; Department of Pathology, Medical University of Graz, Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Bosschieter+J%22">Bosschieter J</searchLink>; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kusuma+VRM%22">Kusuma VRM</searchLink>; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.<br /><searchLink fieldCode="AU" term="%22Ashabere+D%22">Ashabere D</searchLink>; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.<br /><searchLink fieldCode="AU" term="%22Huebner+N%22">Huebner N</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Cotte+J%22">Cotte J</searchLink>; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC no. 5, Oncotype-Uro, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mertens+LS%22">Mertens LS</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Masson-Lecomte+A%22">Masson-Lecomte A</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Liedberg+F%22">Liedberg F</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Cohen+D%22">Cohen D</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Lunelli+L%22">Lunelli L</searchLink>; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Cussenot+O%22">Cussenot O</searchLink>; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22El+Sheikh+S%22">El Sheikh S</searchLink>; Department of Pathology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Volanis+D%22">Volanis D</searchLink>; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Côté+JF%22">Côté JF</searchLink>; Department of Pathology, Pitié Salpétrière Hospital, AP-HP, Pierre et Marie Curie Medical School, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rouprêt+M%22">Rouprêt M</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC no. 5, Oncotype-Uro, Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Haitel+A%22">Haitel A</searchLink>; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Shariat+SF%22">Shariat SF</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Mostafid+AH%22">Mostafid AH</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.<br /><searchLink fieldCode="AU" term="%22Nieuwenhuijzen+JA%22">Nieuwenhuijzen JA</searchLink>; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Zigeuner+R%22">Zigeuner R</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Dominguez-Escrig+JL%22">Dominguez-Escrig JL</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Hacek+J%22">Hacek J</searchLink>; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Zlotta+AR%22">Zlotta AR</searchLink>; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Burger+M%22">Burger M</searchLink>; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Evert+M%22">Evert M</searchLink>; Department of Pathology, University of Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hulsbergen-van+de+Kaa+CA%22">Hulsbergen-van de Kaa CA</searchLink>; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Heijden+AG%22">van der Heijden AG</searchLink>; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22A+L+M+Kiemeney+L%22">A L M Kiemeney L</searchLink>; Department of Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Soukup+V%22">Soukup V</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Molinaro+L%22">Molinaro L</searchLink>; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Gontero+P%22">Gontero P</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Llorente+C%22">Llorente C</searchLink>; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Algaba+F%22">Algaba F</searchLink>; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Palou+J%22">Palou J</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22N'Dow+J%22">N'Dow J</searchLink>; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ribal+MJ%22">Ribal MJ</searchLink>; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Kwast+TH%22">van der Kwast TH</searchLink>; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Babjuk+M%22">Babjuk M</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Sylvester+RJ%22">Sylvester RJ</searchLink>; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Rhijn+BWG%22">van Rhijn BWG</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: b.v.rhijn@nki.nl.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101665661%22">European urology focus</searchLink> [Eur Urol Focus] 2022 Nov; Vol. 8 (6), pp. 1627-1634. <i>Date of Electronic Publication: </i>2022 May 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101665661 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2405-4569 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224054569%22">24054569 </searchLink><i>NLM ISO Abbreviation: </i>Eur Urol Focus <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35577750
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.euf.2022.04.014
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1627
    Titles:
      – TitleFull: T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Beijert IJ
      – PersonEntity:
          Name:
            NameFull: Hentschel AE
      – PersonEntity:
          Name:
            NameFull: Bründl J
      – PersonEntity:
          Name:
            NameFull: Compérat EM
      – PersonEntity:
          Name:
            NameFull: Plass K
      – PersonEntity:
          Name:
            NameFull: Rodríguez O
      – PersonEntity:
          Name:
            NameFull: Subiela Henríquez JD
      – PersonEntity:
          Name:
            NameFull: Hernández V
      – PersonEntity:
          Name:
            NameFull: de la Peña E
      – PersonEntity:
          Name:
            NameFull: Alemany I
      – PersonEntity:
          Name:
            NameFull: Turturica D
      – PersonEntity:
          Name:
            NameFull: Pisano F
      – PersonEntity:
          Name:
            NameFull: Soria F
      – PersonEntity:
          Name:
            NameFull: Čapoun O
      – PersonEntity:
          Name:
            NameFull: Bauerová L
      – PersonEntity:
          Name:
            NameFull: Pešl M
      – PersonEntity:
          Name:
            NameFull: Maxim Bruins H
      – PersonEntity:
          Name:
            NameFull: Runneboom W
      – PersonEntity:
          Name:
            NameFull: Herdegen S
      – PersonEntity:
          Name:
            NameFull: Breyer J
      – PersonEntity:
          Name:
            NameFull: Brisuda A
      – PersonEntity:
          Name:
            NameFull: Calatrava A
      – PersonEntity:
          Name:
            NameFull: Rubio-Briones J
      – PersonEntity:
          Name:
            NameFull: Seles M
      – PersonEntity:
          Name:
            NameFull: Mannweiler S
      – PersonEntity:
          Name:
            NameFull: Bosschieter J
      – PersonEntity:
          Name:
            NameFull: Kusuma VRM
      – PersonEntity:
          Name:
            NameFull: Ashabere D
      – PersonEntity:
          Name:
            NameFull: Huebner N
      – PersonEntity:
          Name:
            NameFull: Cotte J
      – PersonEntity:
          Name:
            NameFull: Mertens LS
      – PersonEntity:
          Name:
            NameFull: Masson-Lecomte A
      – PersonEntity:
          Name:
            NameFull: Liedberg F
      – PersonEntity:
          Name:
            NameFull: Cohen D
      – PersonEntity:
          Name:
            NameFull: Lunelli L
      – PersonEntity:
          Name:
            NameFull: Cussenot O
      – PersonEntity:
          Name:
            NameFull: El Sheikh S
      – PersonEntity:
          Name:
            NameFull: Volanis D
      – PersonEntity:
          Name:
            NameFull: Côté JF
      – PersonEntity:
          Name:
            NameFull: Rouprêt M
      – PersonEntity:
          Name:
            NameFull: Haitel A
      – PersonEntity:
          Name:
            NameFull: Shariat SF
      – PersonEntity:
          Name:
            NameFull: Mostafid AH
      – PersonEntity:
          Name:
            NameFull: Nieuwenhuijzen JA
      – PersonEntity:
          Name:
            NameFull: Zigeuner R
      – PersonEntity:
          Name:
            NameFull: Dominguez-Escrig JL
      – PersonEntity:
          Name:
            NameFull: Hacek J
      – PersonEntity:
          Name:
            NameFull: Zlotta AR
      – PersonEntity:
          Name:
            NameFull: Burger M
      – PersonEntity:
          Name:
            NameFull: Evert M
      – PersonEntity:
          Name:
            NameFull: Hulsbergen-van de Kaa CA
      – PersonEntity:
          Name:
            NameFull: van der Heijden AG
      – PersonEntity:
          Name:
            NameFull: A L M Kiemeney L
      – PersonEntity:
          Name:
            NameFull: Soukup V
      – PersonEntity:
          Name:
            NameFull: Molinaro L
      – PersonEntity:
          Name:
            NameFull: Gontero P
      – PersonEntity:
          Name:
            NameFull: Llorente C
      – PersonEntity:
          Name:
            NameFull: Algaba F
      – PersonEntity:
          Name:
            NameFull: Palou J
      – PersonEntity:
          Name:
            NameFull: N'Dow J
      – PersonEntity:
          Name:
            NameFull: Ribal MJ
      – PersonEntity:
          Name:
            NameFull: van der Kwast TH
      – PersonEntity:
          Name:
            NameFull: Babjuk M
      – PersonEntity:
          Name:
            NameFull: Sylvester RJ
      – PersonEntity:
          Name:
            NameFull: van Rhijn BWG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2022 Nov
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2405-4569
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: European urology focus
              Type: main
ResultId 1